皮下免疫接种kharon1缺陷型婴儿利什曼原虫可诱导免疫原性并保护仓鼠抵抗内脏利什曼病
该研究评估了kharon1基因缺失的婴儿利什曼原虫减毒株(Likh1-/-)在金黄地鼠中的免疫原性和疫苗效力。动物接受一或两次皮下剂量,免疫后一个月及攻击后一个月和八个月评估。Likh1-/-诱导混合Th1/Th2细胞免疫应答和强体液免疫应答,两次免疫组在攻击后两个时间点均显著降低肝脾寄生虫负荷。
要点
- Likh1-/-减毒株在金黄地鼠中具有免疫原性,诱导混合Th1/Th2应答。
- 两次皮下免疫可显著降低攻击后肝脾寄生虫负荷。
- 该策略支持Likh1-/-作为内脏利什曼病免疫预防的候选疫苗进一步开发。
核心结论
- Likh1-/-在金黄地鼠中具有免疫原性,诱导平衡的Th1/Th2免疫应答并有效控制寄生虫,支持其作为内脏利什曼病免疫预防策略进一步开发。
研究设计与样本
- 研究在金黄地鼠(Mesocricetus auratus)中评估Likh1-/-的免疫原性和疫苗效力,动物接受一或两次皮下剂量,免疫后一个月及攻击后一个月和八个月评估。
主要发现
- Likh1-/-免疫诱导混合Th1/Th2细胞免疫应答,免疫动物IFN-γ产生细胞高于未免疫攻击对照,IL-10产生淋巴细胞减少。
- 免疫后关键免疫标志物(IL-1β、TNF、IFN-γ、IL-10、TGF-β)基因表达显著上调,攻击后向更平衡应答调节。
- 免疫触发强体液免疫应答,血清总IgG和IgG2升高,IgG2在所有免疫组占优势并在攻击后保持升高。
- 接受两次皮下Likh1-/-疫苗剂量的动物在攻击后两个时间点肝脾寄生虫负荷均显著低于对照。
临床怎么用
- 提示Likh1-/-减毒活疫苗候选株可能通过皮下接种诱导保护性免疫,但尚未进入人体应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leishmanization, the deliberate inoculation of live parasites into the skin, was historically the only effective immunization strategy against leishmaniasis. Advances in molecular biology have since transformed this concept, particularly through gene-editing technologies targeted attenuation of virulence-associated genes, leading development of a new generation of live attenuated parasites. These next-generation leishmanization approaches preserved broad antigenic diversity while offering improved safety profiles inducing durable protective immunity. Deletion of the kharon1 gene in Leishmania infantum generated an attenuated strain (Likh1-/-) capable of infecting mice while eliciting a robust protective immune response. In the present study, we evaluated the immunogenicity and vaccine efficacy of Likh1-/- in Golden Syrian Hamsters (Mesocricetus auratus), a well-established and representative experimental model of visceral leishmaniasis (VL). Animals received one or two subcutaneous doses of Likh1-/- and were evaluated one month after immunization, as well as one and eight months following challenge with virulent L. infantum promastigotes. Likh1-/- immunization induced a mixed Th1/Th2 cellular immune response, as evidenced by flow cytometry and RT-qPCR analyses. Immunized animals exhibited higher IFN-γ-producing cells compared with non-immunized challenged controls, accompanied by a reduction in IL-10-producing lymphocytes. Gene-expression analysis of key immunological markers (IL-1β, TNF, IFN-γ, IL-10, and TGF-β) revealed marked upregulation post-immunization, followed by modulation toward a more balanced response after challenge. Immunization with Likh1-/- also triggered a strong humoral immune response, with increased serum levels of total IgG and IgG2, with IgG2 predominating across all immunized groups and remaining elevated after challenge. Importantly, animals that received two subcutaneous Likh1-/- vaccine doses exhibited a significant reduction in both hepatic and splenic parasite burdens compared with control animals at both post-challenge time points. Collectively, these findings demonstrate that Likh1-/- is immunogenic in hamsters, eliciting a balanced Th1/Th2 immune response associated with effective parasite control, and support its further development as a promising immunoprophylactic strategy against VL.
引用
- Moreira GJL, Ostolin TLVDP, Moreira POL, et al. Subcutaneous immunization with kharon1-deficient leishmania infantum induces immunogenicity and protects hamsters against visceral leishmaniasis. Vaccine. 2026. PMID: 42442045. doi:10.1016/j.vaccine.2026.128911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。